Prevalence of residual risks of the transfusion-transmitted infections in Riyadh hospitals: A two-year retrospective study

Abstract This study aimed to evaluate the prevalence and trends of transfusion-transmitted infections (TTIs) in two hospitals Riyadh, as well judge best type tests ensure blood transfusion safety. By using serological nucleic acid test (NAT) tests, these donors were screened for human immunodeficiency virus (HIV), hepatitis C (HCV), B (HBV), T-lymphotropic 1 (HTLV-1), 2 (HTLV-2), syphilis, malaria infection a first time donation. Out 58,898 units, 336 units reacted HBsAg, 5,318 HBcAbs, 506 HCV antibodies, 214 HIV Ab/Ag combinations, 206 HTLV 355 syphilis 81 malaria. Moreover, genotypic products showed that 349 HBV DNA, RNA, RNA reflects seriousness residual risk TTI, which is still threat factor transmission blood-borne infectious diseases. It was discovered utilising could increase sensitivities while also lowering TTI risks, improving safety, being cost-effective.